Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 23, 2026Advanced ScienceOpen Access

Anti‐Apoptotic and Neurite‐Protective Nanomedicine Augments Embryonic Stem Cells‐Derived Retinal Ganglion Cell Transplantation in Glaucoma Recovery

View Full Paper
Ask AI
Bookmark
Share

Authors

MCMoxin ChenZJZheng JiaoYWYuanhui Wang

Discussion

Loading...

Member takes

Overview

This approach improves visual function and RGC survival in glaucoma by targeting oxidative stress with nanomedicine.

Key Points

  • To enhance retinal ganglion cell transplantation efficacy in glaucoma using lithium-epigallocatechin gallate nanoparticles.
  • Design of lithium-epigallocatechin gallate nanoparticles (Li-EGCG NPs) for neuroprotection
  • In vitro assessment of nanoparticle effects on ESC-RGCs
  • Use of retinal ischemia/reperfusion injury model for in vivo testing
  • Analysis of neuroprotective pathways via transcriptomic analyses.
  • Li-EGCG NPs reduce oxidative stress and improve apoptotic responses in ESC-RGCs
  • Transplantation with Li-EGCG NPs significantly increases RGC survival
  • Enhanced retinal architecture and restoration of visual function observed in treated models.

Cite This Study

Chen et al. (2026) studied this question.

synapsesocial.com/papers/699ba08472792ae9fd870458https://doi.org/10.1002/advs.202513499
View Full Paper
Ask AI
Bookmark
Share